All News
RheumNow Podcast - RWCS Quick Hits (2.14.20)
Dr. Jack Cush reviews the highlights from the 2020 RWCS meeting in Maui, Hawaii.
Read Article
Does telemedicine really save money OR add to costs? #RWCS2020 @RheumNow https://t.co/673JCW9pkU
Janet Pope Janetbirdope ( View Tweet)
Head to head Ixe vs Adalimumab in PsA is superior on skin with Ixe and equal on jts. MTX was allowed and seemed to improve Adalimumab response not true for Ixe. May change Rx landscape in PsA. #RWCS2020 @RheumNow https://t.co/Ms2w87TKL8
Janet Pope Janetbirdope ( View Tweet)
Yes. Some seronegative RA is same as zero positive. Maybe they have IgA RF. #RWCS2020 @RheumNow https://t.co/MIZY4wXonE
Janet Pope Janetbirdope ( View Tweet)
Mortality rates based on ab status in SSc. Dr. Pope @RheumNow @RWCSmtg #RWCS2020 https://t.co/Wo34p1R4cl
Dr. Rachel Tate uptoTate ( View Tweet)
Remember that one spot of PsO that won’t go away on your well controlled PsO patient? It may be due to resident T cells locally. Now what can we do about it? Drs. Ruderman and Kavanaugh @RheumNow @RWCSmtg #RWCS2020 https://t.co/1nrtgxOGYW
Dr. Rachel Tate uptoTate ( View Tweet)
Telemedicine in rheumatology. Likely not appropriate for all visits with inflammatory arthritis. Aren’t we the last hold outs of doing a physical exam? #RWCS2020 @RheumNow https://t.co/2U9QO5jl3o
Janet Pope Janetbirdope ( View Tweet)
Check out CORRONA data regarding the use of Otezla and bDMARDs. We tend to use it in women, pts w/ higher BMI, depression, and those with prior bDMARD failure. @RheumNow @RWCSmtg #RWCS2020 https://t.co/t63TTCLTk6
Dr. Rachel Tate uptoTate ( View Tweet)
Best advice if taking pics of slides. Get Microsoft office lens free ap. Ends your trapezoid pics. #RWCS2020 @RheumNow https://t.co/9LqwxEImLM
Janet Pope Janetbirdope ( View Tweet)
Cool way to visualize Rx options in PsA. Data from A Kavanaugh #RWCS2020 @RheumNow https://t.co/XobnUbVhiA
Janet Pope Janetbirdope ( View Tweet)
Guidelines from GRAPPA are more inclusive than ACR. ACR lacks most MOA drugs other than TNFis #RWCS2020 @RheumNow https://t.co/7k4HCllzfE
Janet Pope Janetbirdope ( View Tweet)
EXCEED SECU vs ADA results in treatment naive pts. #RWCS2020 @RheumNow @RWCSmtg https://t.co/VF7Y7p4H2H
Dr. Rachel Tate uptoTate ( View Tweet)
REMS is nothing to sleep about Not REM sleep but FDA may impose risk mitigation strategies post marketing. It applies to some drugs such as Coxibs and Actemra vs Etanercept ENTRACT RCT for CV safety and Belimumab in SLE for safety. All equally safe #RWCS2020 @RheumNow https://t.co/b3rDlcABwL
Janet Pope Janetbirdope ( View Tweet)
A review of the 2015 GRAPPA guidelines from Drs. Kavanaugh and Ruderman #RWCS2020 @RheumNow @RWCSmtg https://t.co/45P3VzR4hj
Dr. Rachel Tate uptoTate ( View Tweet)
SEAM results make the case that ETN + MTX may have improved skin scores compared to ETN or MTX monotherapy. @RheumNow @RWCSmtg #RWCS2020 https://t.co/CErP4HOejA
Dr. Rachel Tate uptoTate ( View Tweet)
PsA domains, as a way to discuss the heterogeneity of disease. Drs. Kavanaugh and Ruderman #RWCS2020 @RheumNow @RWCSmtg https://t.co/NKwE4xj63l
Dr. Rachel Tate uptoTate ( View Tweet)
Axial SpA if on adalimumab should MTX be used to decrease ABs? Study says YE and pretreat so MTX first. Not standard of care. #RWCS2020 @RheumNow https://t.co/d7YOwqoUwN
Janet Pope Janetbirdope ( View Tweet)
Secukinumab is not stat superior to Adalimumab for primary endpoint in PsA. Equal but some features are better. Do 2 IL17 H2H trials make you change order of biological Rx? #RWCS2020 @RheumNow https://t.co/ZRc1Y4MTQ4
Janet Pope Janetbirdope ( View Tweet)
Joint surgeries are more common in PsA compared to the general population, even in the biologics era. Drs. Ruderman/Kavanaug #RWCS2020 @RWCSmtg https://t.co/R0BPUQvLV7
Dr. John Cush RheumNow ( View Tweet)
Having PsA involves 2-3-4 domains in 74% of pts.. Drs. Ruderman/Kavanaug #RWCS2020 @RWCSmtg https://t.co/hJUxqQYZf3
Dr. John Cush RheumNow ( View Tweet)